Roche Holding AG

ROP

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    112,774

Roche Holding AG News & Analysis

personal-finance

The US dollar looks overvalued. Should individual investors care?

Some things are a lot more important to professional investors than everybody else.
stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far.
stocks

Obesity drug stocks: Where to invest now

Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,697.50139.10-1.57%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,435.24406.38-1.78%
NASDAQ23,879.20550.69-2.25%
Nikkei 22556,967.052,477.16-4.17%
NZX 50 Index14,102.30144.95-1.02%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,597.60132.80-1.52%
SSE Composite Index3,521.4056.22-1.57%

Market Movers